• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2017
Event Type  malfunction  
Manufacturer Narrative
Age - average, date of event ¿ estimated, treatment/therapy start date - estimated, the unique device identifier (udi) is unknown because the part number and lot number were not provided.Date of implant ¿ estimated.The devices remain implanted and are not returning.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The other devices and events are filed under separate medwatch report numbers.Attached article titled, "everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of st-segment elevation myocardial infarction: a randomized controlled trial".
 
Event Description
It was reported in a research article that compared the performance of absorb scaffolds and xience stents.The following may be related to each implanted device: mal-apposed struts, stent recoil, late lumen loss (obstruction/occlusion), and stenosis.The article is titled: "everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of st-segment elevation myocardial infarction: a randomized controlled trial".Please see the attached article for more details.
 
Manufacturer Narrative
The devices remain implanted and were not returned for analysis.A review of the electronic lot history records (elhr) and lot level similar incident reviews for this product were not performed because the part and lot numbers were not reported and the products were not returned for analysis.The investigation determined a conclusive cause for the reported patient-device incompatibilities (wall appositions and recoils) cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16134949
MDR Text Key308612258
Report Number2024168-2023-00376
Device Sequence Number1
Product Code PNY
Combination Product (y/n)Y
Reporter Country CodeNO
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age61 YR
Patient SexMale
-
-